New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
Global GP Conference comes to Australia
Over 3000 delegates from around the World will gather at the 50th celebration of WONCA to reconnect and revive General Practice, sharing knowledge and learnings on access, equity, funding, and multidisciplinary care teams. This includes networking with Australian and overseas GPs and in particular learning about primary care practices in other countries.
Australian Health Journal met with Dr Nicole Higgins, President of RACGP in transit at Brisbane Airport recently and she spoke about the $6 Billion allocated in the Federal Budget in May as a significant achievement for General Practice investment. She also emphasised this announcement reinforced GPs should be at the centre of multidisciplinary care teams to ensure continuity of care and better health outcomes.
Evolution in consumer diagnostics with saliva based pathology
Since the COVID-19 pandemic, consumer diagnostics have rapidly advanced, with more people becoming aware of and comfortable using at-home testing. These tests provide greater convenience, control, and empowerment, allowing individuals to monitor their health without immediately consulting a healthcare professional. Recently, this shift has been particularly impactful in areas such as pregnancy testing, where saliva-based diagnostics now enable earlier and more accessible detection.
Episode 4 Season 1
Profiling “Inside MS” for trainee doctors understanding MRI data. 10 Year anniversary of the TAVI heart procedure. White Coats Foundation also talk about clinical trials.
Australian Healthcare Week 2019: Pitch Fest Finalist Lumin
Startup company Lumin was a Pitch Fest Finalist at last week’s Australian Healthcare Week Expo in Sydney. The Lumin platform is used in aged care where loneliness and isolation can be a trigger for stroke and dementia. Lumin helps the connection to care providers, family members and duress monitoring services in a device that has been designed for those with dementia, vision impairment or find complex devices difficult to use.
Managing Director and Co-Founder Paul Wilson spoke at the Mepacs booth with Anne Dao from Australian Health Journal about the market they target and the design of the user experience, including the remote servicing and monitoring. The integration allows the monitoring team in the call centre see and hear the personal raising the alarm. Mepacs is a provider of personal duress alarms and have teamed up with Lumin.
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).